{"filing":{"accession_number":"0001213900-26-060662","cik":"0001560293","ticker":"TNONW","company_name":"Tenon Medical, Inc.","form":"8-K","filing_date":"2026-05-22","report_date":null,"primary_document":"ea0291962-8k_tenon.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1560293/000121390026060662/ea0291962-8k_tenon.htm"},"events":[{"id":10622,"run_id":9320,"accession_number":"0001213900-26-060662","anchor_item_number":"3.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"summary":"Tenon Medical received a written notice from Nasdaq on May 21, 2026, stating it no longer complies with the minimum stockholders' equity requirement of $2,500,000 under Nasdaq Listing Rule 5550(b)(1), having reported only $1,895,000 in stockholders' equity as of March 31, 2026. The company has 45 days to submit a compliance plan or face delisting, with no assurance of success. This is a classic delisting-risk disclosure under Item 3.01.","company_name":"Tenon Medical, Inc.","ticker":"TNONW","filing_date":"2026-05-22","submitted_at":null,"items":[{"id":6984,"accession_number":"0001213900-26-060662","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"Tenon Medical received a written notice from Nasdaq on May 21, 2026, stating it no longer complies with the minimum stockholders' equity requirement of $2,500,000 under Nasdaq Listing Rule 5550(b)(1), having reported only $1,895,000 in stockholders' equity as of March 31, 2026. The company has 45 days to submit a compliance plan or face delisting, with no assurance of success. This is a classic delisting-risk disclosure under Item 3.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:52:52.095261+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":6984,"accession_number":"0001213900-26-060662","item_number":"3.01","item_title":"Notice of Delisting or Failure to Satisfy a Continued","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"Tenon Medical received a written notice from Nasdaq on May 21, 2026, stating it no longer complies with the minimum stockholders' equity requirement of $2,500,000 under Nasdaq Listing Rule 5550(b)(1), having reported only $1,895,000 in stockholders' equity as of March 31, 2026. The company has 45 days to submit a compliance plan or face delisting, with no assurance of success. This is a classic delisting-risk disclosure under Item 3.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-13T00:52:52.095261+00:00","company_name":"Tenon Medical, Inc.","ticker":"TNONW","filing_date":"2026-05-22"}]}